Medifast, Inc. to Present at the 28th Annual Canaccord Adams Global Growth Conference
Tuesday, August 05, 2008 4:01 PM
Symbols: MED

OWINGS MILLS, Md., Aug. 5 /PRNewswire-FirstCall/ -- Medifast, Inc. (NYSE: MED) announced today that Michael S. McDevitt, Chief Executive Officer and Chief Financial Officer, will make a presentation at the Canaccord Adams Global Growth Conference on Thursday, August 14, 2008, at 2:30 p.m. ET at the InterContinental Boston Hotel.

Interested parties can access a live web cast of the event at: http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=MED&item_id=1887882. The web cast will be available for 60 days.

About Medifast, Inc.

Medifast (NYSE: MED) is the leading easy-to-use, clinically proven portion-controlled weight loss program. Medifast has been recommended by 15,000 physicians and used by over one million customers. It is committed to enriching lives by providing innovative choices for lasting health. Medifast programs have been proven effective through studies by major university teaching hospitals. The company sells its products and programs via four unique distribution channels: 1) the web and national call centers, 2) national network of physicians, 3) medically supervised Medifast Weight Control Centers, and 4) the Take Shape For Life direct-selling division, a network of health coaches. Medifast was founded in 1980 and is located in Owings Mills, Maryland. For more information, log onto http://www.ChooseMedifast.com.

     Contacts:
     Brendan Connors                      Lytham Partners, LLC
     Vice President - Finance             Joe Diaz
     Medifast, Inc.                       Robert Blum
     (410) 581-8042                       Joe Dorame
     ir@choosemedifast.com                (602) 889-9700

SOURCE Medifast, Inc.

(Source: PR Newswire )

More Options



Subscribe to Email Alerts rss feed or RSS feeds rss feed for articles from more than 300 contributors and press releases, SEC filings and full text news from thousands of sources.


 
Rate :  Rate this Commentary  


 Number of Comments (0) Post Comment
 
  
Good Rating(+1)    Bad Rating(-1)
No Data Found

 
Enter Symbol
Enter Search String
Bookmark This Article
Email Article

Send this article by email


Recipient's Name
Recipient's E-mail
Your Name
Your E-mail
Related Quotes

 
  Home | Login |Research | Earnings | Scans | Chat Rooms | Charts | Submit Article | Join Blog Network | Contributors | Subscribe to RSS

copryright 2008 all rights reserved